Vanguard Personalized Indexing Management, LLC Denali Therapeutics Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 11,377 shares of DNLI stock, worth $178,391. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,377
Previous 12,890
11.74%
Holding current value
$178,391
Previous $375,000
38.4%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding DNLI
# of Institutions
241Shares Held
111MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$207 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$193 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$188 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$85.9 Million0.02% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$84 Million0.55% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.1B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...